REMOVE ADS

Nuformix Regulatory News (NFX)

Nuformix Information

Share Price Information for Nuformix (NFX)

Share Price is delayed by 15 minutes

Get Live Data

0.18 0.0115 (6.39%)

Bid:

0.17

Ask:

0.19

Spread: 0.02 (11.765%)

Market Cap: £5.00m

Last checked at -

REMOVE ADS

Date		Source	Headline
31st Jan 2018	7:00 am	RNS	NXP002 Pilot Study in Lung and Liver Fibrosis
15th Dec 2017	7:30 am	RNS	Agreement to License NXP001
14th Dec 2017	7:00 am	RNS	Dr Andy Richards Chairs Advisory Panel - New Appts
12th Dec 2017	4:40 pm	RNS	Second Price Monitoring Extn
12th Dec 2017	4:35 pm	RNS	Price Monitoring Extension
6th Dec 2017	7:00 am	RNS	Grant of Warrants
1st Dec 2017	7:30 am	RNS	Appointment of Broker
10th Nov 2017	10:19 am	RNS	Holding(s) in Company
1st Nov 2017	12:23 pm	RNS	Holding(s) in Company
23rd Oct 2017	7:30 am	RNS	Holding(s) in Company
19th Oct 2017	7:00 am	RNS	NXP001 agreement for pilot bioequivalence study
16th Oct 2017	7:00 am	RNS	Admission and First Dealings
16th Oct 2017	7:00 am	RNS	Cancellation Notice and Re-Admission
13th Oct 2017	3:44 pm	RNS	Change of Name
13th Oct 2017	12:35 pm	RNS	Result of Meeting and Completion of Acquisition
13th Oct 2017	7:00 am	RNS	Half-year Report
22nd Sep 2017	7:00 am	RNS	Final Results and Annual Report
15th Sep 2017	2:15 pm	RNS	Prospectus re: Proposed Acquisition of Nuformix
20th Apr 2017	7:00 am	RNS	Convertible Loan Agreement
23rd Dec 2016	7:00 am	RNS	Half-year Report
21st Sep 2016	7:00 am	RNS	Accounts for the period ended 31 March 2016
21st Sep 2016	7:00 am	RNS	New Accounting Ref Date
16th Sep 2016	1:03 pm	RNS	Possible Acquisition and Suspension of Trading
29th Mar 2016	7:00 am	RNS	Half Yearly Report
24th Feb 2016	7:00 am	RNS	Broker Appointment and Corporate Update
17th Dec 2015	7:00 am	RNS	Publication of Prospectus and First Dealings